NCT06859281View on ClinicalTrials.gov

Safety, Tolerability, and Pharmacokinetic Profile of Grammidin, a Metered Dose Topical Spray in Healthy Volunteers

PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 10, 2024

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2026

Conditions
Pharyngitis
Interventions
DRUG

Grammidin neo

Grammidin neo, lozenges, 1 lozenge to be taken once under fed conditions.

DRUG

Grammidin, a metered dose topical spray

Grammidin, a metered dose topical spray, 4 sprays to be taken once under fed conditions.

Trial Locations (1)

196143

RECRUITING

"Limited Liability Company Research Center Eco-Safety", Saint Petersburg

All Listed Sponsors
lead

Valenta Pharm JSC

INDUSTRY